Artal Group as of Sept. 30, 2018
Portfolio Holdings for Artal Group
Artal Group holds 98 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Weight Watchers International | 27.8 | $1.1B | 15M | 71.99 | |
| Lexicon Pharmaceuticals (LXRX) | 16.7 | $643M | 60M | 10.67 | |
| Goldman Sachs (GS) | 6.1 | $236M | 1.1M | 224.24 | |
| Bank of America Corporation (BAC) | 3.5 | $133M | 4.5M | 29.46 | |
| Beigene (BGNE) | 2.7 | $103M | 600k | 172.22 | |
| General Motors Company (GM) | 2.6 | $101M | 3.0M | 33.67 | |
| Morgan Stanley (MS) | 2.4 | $93M | 2.0M | 46.57 | |
| Wells Fargo & Company (WFC) | 2.0 | $79M | 1.5M | 52.56 | |
| Rubius Therapeutics | 1.8 | $70M | 2.9M | 24.00 | |
| Celgene Corporation | 1.8 | $67M | 750k | 89.49 | |
| Scholar Rock Hldg Corp (SRRK) | 1.6 | $62M | 2.4M | 25.75 | |
| Nektar Therapeutics (NKTR) | 1.6 | $61M | 1.0M | 60.96 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $61M | 700k | 87.52 | |
| Amicus Therapeutics (FOLD) | 1.6 | $61M | 5.0M | 12.09 | |
| Acceleron Pharma | 1.5 | $57M | 1.0M | 57.23 | |
| Tesaro | 1.3 | $51M | 1.3M | 39.01 | |
| Bristol Myers Squibb (BMY) | 1.2 | $47M | 750k | 62.08 | |
| Atara Biotherapeutics (ATRA) | 1.1 | $41M | 1.0M | 41.35 | |
| Blueprint Medicines (BPMC) | 1.0 | $39M | 500k | 78.06 | |
| Fate Therapeutics (FATE) | 0.9 | $36M | 2.2M | 16.29 | |
| Medicines Company | 0.8 | $30M | 1.0M | 29.91 | |
| Anaptysbio Inc Common (ANAB) | 0.8 | $30M | 300k | 99.77 | |
| Array BioPharma | 0.8 | $29M | 1.9M | 15.20 | |
| Alibaba Group Holding (BABA) | 0.7 | $27M | 165k | 164.75 | |
| Bluebird Bio (BLUE) | 0.7 | $26M | 175k | 146.00 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.7 | $25M | 1.3M | 19.35 | |
| Accelr8 Technology | 0.6 | $23M | 1.0M | 22.95 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $23M | 300k | 77.12 | |
| Zogenix | 0.5 | $20M | 400k | 49.60 | |
| Xencor (XNCR) | 0.5 | $20M | 500k | 38.97 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $19M | 200k | 96.97 | |
| SPDR S&P Biotech (XBI) | 0.5 | $19M | 200k | 95.87 | |
| Micron Technology (MU) | 0.5 | $18M | 400k | 45.23 | |
| Citigroup (C) | 0.5 | $18M | 250k | 71.74 | |
| Inflarx Nv (IFRX) | 0.5 | $17M | 500k | 34.32 | |
| Albireo Pharma | 0.4 | $17M | 500k | 32.96 | |
| Fibrogen (FGEN) | 0.4 | $15M | 250k | 60.75 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.4 | $15M | 500k | 30.67 | |
| Sage Therapeutics (SAGE) | 0.4 | $14M | 100k | 141.25 | |
| Argenx Se (ARGX) | 0.4 | $14M | 185k | 75.84 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.4 | $14M | 1.0M | 13.92 | |
| Wynn Resorts (WYNN) | 0.3 | $13M | 100k | 127.06 | |
| American Airls (AAL) | 0.3 | $12M | 300k | 41.33 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $11M | 150k | 75.50 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $11M | 50k | 214.14 | |
| Denali Therapeutics (DNLI) | 0.3 | $11M | 500k | 21.74 | |
| Solid Biosciences | 0.3 | $11M | 225k | 47.18 | |
| Nio Inc spon ads (NIO) | 0.3 | $11M | 1.5M | 6.98 | |
| Audentes Therapeutics | 0.3 | $9.9M | 250k | 39.59 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $9.8M | 400k | 24.62 | |
| Zafgen | 0.2 | $9.4M | 800k | 11.69 | |
| Cymabay Therapeutics | 0.2 | $8.9M | 800k | 11.08 | |
| Selecta Biosciences (RNAC) | 0.2 | $8.7M | 562k | 15.55 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $7.9M | 700k | 11.25 | |
| Clementia | 0.2 | $7.7M | 692k | 11.15 | |
| Restorbio | 0.2 | $7.6M | 500k | 15.14 | |
| Replimune Group (REPL) | 0.2 | $7.2M | 450k | 16.10 | |
| D Stemline Therapeutics | 0.2 | $6.6M | 400k | 16.60 | |
| Dicerna Pharmaceuticals | 0.2 | $6.5M | 425k | 15.26 | |
| Ac Immune Sa (ACIU) | 0.2 | $6.0M | 750k | 8.00 | |
| Spero Therapeutics (SPRO) | 0.2 | $6.3M | 600k | 10.51 | |
| Translate Bio | 0.2 | $6.0M | 600k | 10.00 | |
| 111 Inc ads (YI) | 0.2 | $6.1M | 450k | 13.52 | |
| LogMeIn | 0.1 | $5.8M | 65k | 89.11 | |
| Agenus (AGEN) | 0.1 | $5.9M | 2.8M | 2.14 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $5.7M | 200k | 28.65 | |
| Sangamo Biosciences (SGMO) | 0.1 | $5.1M | 300k | 16.95 | |
| Marinus Pharmaceuticals | 0.1 | $5.0M | 500k | 10.00 | |
| Aerpio Pharmaceuticals | 0.1 | $4.8M | 1.6M | 3.09 | |
| Avrobio Ord (AVRO) | 0.1 | $5.2M | 100k | 51.87 | |
| Crispr Therapeutics (CRSP) | 0.1 | $4.4M | 100k | 44.35 | |
| Akebia Therapeutics (AKBA) | 0.1 | $4.2M | 475k | 8.83 | |
| Aduro Biotech | 0.1 | $4.0M | 550k | 7.35 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $4.2M | 300k | 13.94 | |
| Chimerix (CMRX) | 0.1 | $3.9M | 1.0M | 3.89 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $4.0M | 200k | 20.13 | |
| Y Mabs Therapeutics (YMAB) | 0.1 | $4.0M | 150k | 26.56 | |
| Flextronics International Ltd Com Stk (FLEX) | 0.1 | $3.3M | 250k | 13.12 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $3.3M | 250k | 13.20 | |
| Elanco Animal Health (ELAN) | 0.1 | $3.5M | 100k | 34.89 | |
| Conatus Pharmaceuticals | 0.1 | $2.9M | 500k | 5.80 | |
| Tricida | 0.1 | $3.1M | 100k | 30.55 | |
| Intellia Therapeutics (NTLA) | 0.1 | $2.6M | 90k | 28.62 | |
| Miragen Therapeutics | 0.1 | $2.8M | 500k | 5.58 | |
| Synlogic | 0.1 | $2.8M | 200k | 14.21 | |
| Krystal Biotech (KRYS) | 0.1 | $2.6M | 150k | 17.58 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $2.8M | 200k | 14.24 | |
| Tg Therapeutics (TGTX) | 0.1 | $2.2M | 400k | 5.60 | |
| Adverum Biotechnologies | 0.1 | $2.4M | 400k | 6.05 | |
| Homology Medicines | 0.1 | $2.3M | 100k | 22.86 | |
| Magenta Therapeutics | 0.1 | $2.4M | 200k | 12.01 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.0M | 111k | 18.46 | |
| Novavax | 0.0 | $940k | 500k | 1.88 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $870k | 150k | 5.80 | |
| Noveliontherapeuti.. | 0.0 | $759k | 256k | 2.96 | |
| Unity Biotechnology | 0.0 | $815k | 50k | 16.30 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $405k | 500k | 0.81 | |
| Oncocyte | 0.0 | $375k | 150k | 2.50 |
